相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Antiphosphatidylserine/Prothrombin Antibodies (aPS/PT) as Potential Markers of Antiphospholipid Syndrome
Alexandru Vlagea et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2013)
The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome
A. Hoxha et al.
CLINICA CHIMICA ACTA (2012)
Antibodies to phosphatidylserine/prothrombin complex as an additional diagnostic marker of APS?
P. Zigon et al.
LUPUS (2012)
Antiphosphatidylserine/prothrombin antibodies in primary antiphospholipid syndrome
A. Hoxha et al.
LUPUS (2012)
Clinical significance of anti-annexin V antibody in acute cerebral ischemia
Kee Ook Lee et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2011)
Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus
M. J. Adams et al.
LUPUS (2011)
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
V. Pengo et al.
THROMBOSIS RESEARCH (2010)
Anti-prothrombin antibodies are associated with thrombosis in children
Olof Rask et al.
THROMBOSIS RESEARCH (2010)
Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus
Peter Szodoray et al.
AUTOIMMUNITY (2009)
Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: Identical or distinct diagnostic tools for antiphospholipid syndrome?
Troy D. Jaskowski et al.
CLINICA CHIMICA ACTA (2009)
Study of Phosphatidylserine-dependent Anti-prothrombin Antibody in Cerebral Infarction
Hirohisa Okuma et al.
INTERNAL MEDICINE (2009)
Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V617F status, clonality, and antiphospholipid antibodies
B. Robertson et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study
N. Bizzaro et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Does the anti-prothrombin antibodies measurement provide additional information in patients with thrombosis?
Nathalie Bardin et al.
IMMUNOBIOLOGY (2007)
The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant
Thomas Sailer et al.
THROMBOSIS RESEARCH (2007)
Human monoclonal antibodies against the complex of phosphatidylserine and prothrombin from patients with the antiphospholipid antibodies
T. Horita et al.
LUPUS (2007)
Prevalence of antibodies against oxidised LDL in a cohort of 163 patients with positive anti-phospholipid antibodies and recent thrombosis
H Locht et al.
RHEUMATOLOGY INTERNATIONAL (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Prevalence and clinical correlates of anti-phospholipid antibodies in South Africans with systemic lupus erythematosus
T Gould et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2006)
Antiphospholipid antibody tests: spreading the net
ML Bertolaccini et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
A prospective study of antibodies to β2-glycoprotein I and prothrombin, and risk of thrombosis
R Forastiero et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Acquired activated protein C resistance associated with IgG antibodies against β2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism
J Nojima et al.
CLINICAL CHEMISTRY (2005)
High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis
K Ishikura et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
The association of antibodies to cardiolipin, β2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus
S Koskenmies et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Autoantibodies against phosphatidylserine-prothrombin complex in patients with systemic sclerosis
M Hasegawa et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
Anti-β2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome
M Galli et al.
BLOOD (2003)
Risk of ischemic stroke associated with functional thrombin-activatable fibrinolysis inhibitor plasma levels
A Santamaría et al.
STROKE (2003)
A study on associations between antiprothrombin antibodies, antiplasminogen antibodies and thrombosis
MJA Simmelink et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Anti-prothrombin antibodies cause thrombosis in a novel qualitative ex-vivo animal model
S Haj-Yahja et al.
LUPUS (2003)
A perturbation of antithrombin-III and protein C coupling associates with an increase of anti-β2-glycoprotein I antibody in non-antiphospholipid antibody syndrome cerebral ischemia
WH Chen et al.
BLOOD COAGULATION & FIBRINOLYSIS (2002)
Antiprothrombin antibodies in patients with systemic lupus erythematosus or with primary antiphospholipid syndrome
F Salcido-Ochoa et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2002)
Antibodies to prothrombin, factor V, and β2-glycoprotein I and vascular access thrombosis
JJ Sands et al.
ASAIO JOURNAL (2001)
Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus
J Nojima et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome
MJ Adams et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome
S Donohoe et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)